Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xinjiang Qimu Medical Research Institute is a specialized medical research organization based in Urumqi, China, dedicated to the treatment of chronic and refractory skin diseases. The institute focuses on the development of proprietary therapies for conditions such as psoriasis, eczema, and vitiligo, often integrating traditional Chinese medicine principles with modern dermatological research. It operates in conjunction with Xinjiang Qimu Biotechnology to manufacture and distribute its therapeutic products. The institute is recognized for its Qimu series of treatments, which are utilized in specialized clinics across China. Its research efforts are primarily directed toward improving the quality of life for patients with long-term dermatological issues through non-hormonal topical interventions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xinjiang Qimu Medical Research Institute.